Abbott Laboratories (ABT) Technical Analysis
Current Price: $112.62
Date: February 13, 2026
Abbott Laboratories has been demonstrating a recovery from its recent dips, with a close at $112.62 on February 13, 2026. The stock has been trading within a range, with technical indicators pointing to a potential shift in momentum as key levels are tested.
Technical Indicator Summary Table
| Indicator | Current Value | Key Levels | Analysis |
|---|---|---|---|
| Current Price | $112.62 | — | Trading within Bollinger Bands, approaching a potential resistance at the upper band |
| 20-day SMA | $111.30 | Price > SMA indicates bullish | Price is above, indicating short-term bullish momentum |
| 50-day SMA | $119.57 | Price < SMA indicates bearish | Medium-term resistance, suggests ongoing trend reversal challenges |
| 100-day SMA | $124.38 | Price < SMA indicates bearish | Signifies long-term resistance level, still not supporting long-term bullishness |
| RSI | 44.48 | Neutral: 30-70, Overbought > 70, Oversold < 30 | Suggests mild bullish momentum; still has room for growth before being overbought |
| Bollinger Bands | $101.78 - $120.82 | Price near the middle band indicates neutrality | Stability with potential for further gains as it approaches the upper band |
| MACD | -2.41 (Histogram: 0.93) | Positive Histogram = Bullish | Shows a bullish signal with MACD above signal line, indicating potential trend reversal |
| On Balance Volume | 242.61M | Rising OBV confirms bullish trends | Increasing OBV suggests accumulation and buying interest is strengthening |
Moving Averages
ABT's price of $112.62 is currently above its 20-day SMA of $111.30, signifying recent bullish activity. The upward breach suggests that short-term buying power is increasing, potentially leading to further gains. However, the 50-day SMA at $119.57 and the 100-day SMA at $124.38 present significant resistance levels. These higher SMAs indicate that while there is a rebound from the short-term sell-off, challenges remain to establish a sustained long-term bullish trend. Overcoming the 50-day SMA would be crucial for confirming a reversal to more broadly bullish conditions.
Relative Strength Index (RSI)
The current RSI stands at 44.48, which resides in the neutral zone between 30 and 70, but indicates a slightly bullish sentiment. This low to mid-range RSI implies that the stock is not overbought and suggests room for further price increases. However, a move closer to 70 would be needed to raise concerns about potential overbought conditions, giving some capacity for bullish expansion without immediate corrective pressure.
Bollinger Bands
ABT is near its middle Bollinger Band, at $111.30, heading upwards towards the upper band at $120.82. This position signals a potential bullish momentum if the stock can break towards the upper boundary, usually indicating increased volatility and potential upsurge. The trajectory towards the upper band suggests positive market sentiment but requires a confirmation through a breach to cement a bullish breakout.
MACD
The MACD line at -2.41, with a positive histogram reading of 0.93, indicates the beginning of a bullish crossover. The positive histogram reveals that the MACD is above the signal line, inferring growing upward momentum. This increases the likelihood of continued price recovery as momentum shifts from bearish to bullish, especially if the MACD continues rising.
On Balance Volume (OBV)
With the OBV at 242.61 million and climbing, this suggests increasing buying volume, an affirmative signal for bullish market sentiment. The sustained rise in OBV, alongside price increases, connotes that accumulative buying pressure is supporting current price levels, indicating potentially further upward movement.
Candlestick Patterns
Recent candlestick patterns reveal gradual recovery with recent sessions reflecting slight upward pressure and close just above opening prices, fostering a neutral-to-bullish stance. The consistent close slight above opens reflects moderate bullish control, matching the supportive short-term moving averages to suggest potential further gains if key resistances are surpassed.
Summary
Abbott Laboratories appears to be embarking on a short-term upward correction phase, supported by rising OBV and a bullish MACD crossover. The stock's movement above the 20-day SMA supports the potential for more gains if it surpasses the rigorous barriers posed by its 50-day and 100-day SMAs. Continued accumulation suggests sustained buying interest as it tackles these resistances.
However, without breaking these key SMA levels, long-term bullish confirmations remain elusive. Monitoring price action near $119.57 will be vital for determining sustained recovery in stock price.
Traders may consider entering positions around current levels, looking for a breakout beyond the 50-day SMA, while setting stop-loss orders below the most recent low near $110 to manage downside risk. A breakout would indicate a short-term target approaching $120.82 (upper Bollinger Band).
**